Interested in sharing the research? You can order print copies of many research publications.

Order Reprints

Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

Resources for Medicare Beneficiaries: Navigating the Coverage Gap | How the Gap May Affect You

This six-page brochure helps Medicare Part D recipients and caregivers better understand the Medicare coverage gap, often referred to as the “donut hole.” During the “donut hole,” Medicare temporarily stops paying for prescriptions and recipients must pay the entire costs of the medicines by themselves. This brochure explains:

  • Who may be affected by the coverage gap;
  • How the coverage gap works; and
  • How to track covered drug expenses (a sample expense log is provided).

Spanish version of this brochure also is available (2009).

Commentary and Testimony Page

NPC Comments on CMS' Proposed Changes to Protected Classes

March 7, 2014Marilyn B. TavennerAdministratorCenters for Medicare & Medicaid ServicesU.S. Department of Health and Human Services200 Independence...
Blog Post

NPC Asks CMS to Consider Patients’ Individual Treatment Effects In Part D Rulemaking

The National Pharmaceutical Council (NPC) today asked the Centers for Medicare and Medicaid Services (CMS) to consider maintaining “protected classes...
Newsletter Volume

E.V.I.dently November 2013

MessageCER Collaborative Is Assessing Evidence and Informing Decision-MakingToday we’re faced with an ever-growing availability of health information...
Newsletter Volume

E.V.I.dently October 2013

Message from NPCWhen Health Insurance Exchange “Dust” Settles, Usable CER Will Be CriticalBy Dan LeonardOn October 1, the debut of the federal...
Press Release

Fellowship in Policy Impact of Comparative Effectiveness Research Awarded By National Pharmaceutical Council and George Washington University

[[{"fid":"25703","view_mode":"teaser","type":"media","link_text":null,"attributes":{"height":"360","width":"240","border":"0","alt":"chuck-shih","...
Press Release

Study Quantifies Impact of Pharmaceuticals on Enhanced Productivity

(WASHINGTON, DC, August 1, 2012)–The costs to employers of chronic health conditions on employee productivity are well documented, but few studies...
Press Release

New Survey Shows Employers Eyeing CER, PCORI for Health Information

Washington, DC, June 22, 2011--Employers are aware of comparative effectiveness research (CER) and its potential to answer critical questions about...
Press Release

New Report Urges Employers, Researchers and Policy Makers to Rethink How They Measure Health Care Results

San Francisco, CA & Washington, DC (February 28, 2011) -- Understanding the full value of improved health, including improvements in workforce...
Commentary and Testimony Page

NPC Comments on CMS' Proposed Changes to Protected Classes

March 7, 2014Marilyn B. TavennerAdministratorCenters for Medicare & Medicaid ServicesU.S. Department of Health and Human Services200 Independence...
Commentary and Testimony Page

What Will 2011 Hold for CER and PCORI?

When future historians consider health care, they may well look back on 2010 as a watershed year in America. The issues and events that occurred last...
Commentary and Testimony Page

NPC Reflects on Changes in 2010

It’s been a year of great change not only for the biopharmaceutical industry, but for the National Pharmaceutical Council as well. With these changes...
Commentary and Testimony Page

A Look at Value-Based Insurance Design

This month, NPC released a new report, “Value-Based Insurance Design Landscape Digest,” focusing on an important approach being used by leading edge...
YouTube Videos

Can We Bring Clarity, Consistency and Transparency to Payer Coverage Decisions?

There is a bit of a "black box" around the formulary decision-making process. As a result, decisions about treatment access are often unpredictable...
YouTube Videos

How Do Payers Consider Individual Treatment Effects?

Dr. Robert Epstein, former chief medical officer and senior vice president of medical affairs at Medco Health, explains that heterogeneity, or...
YouTube Videos

Comparative Effectiveness Research in Medicare Decision-Making

At the June 2011 Drug Information Association Annual Meeting, NPC asked Dr. Marcel Salive for his thoughts on how comparative effectiveness research...
YouTube Videos

IBI's Tom Parry on Employers and Health Investments

Integrated Benefits Institute President Tom Parry, PhD, sat down with NPC to discuss how employers today are defining the value of their health...
Blog Post

NPC Asks CMS to Consider Patients’ Individual Treatment Effects In Part D Rulemaking

The National Pharmaceutical Council (NPC) today asked the Centers for Medicare and Medicaid Services (CMS) to consider maintaining “protected classes...
Blog Post

NPC Webinar: Can We Bring Clarity, Consistency and Transparency to Payer Coverage Decisions?

Why are some treatments covered under a health care plan, while other treatments are not? How do payers evaluate the information needed to make...
Blog Post

A Step Toward Clear, Consistent, Transparent Formulary Decisions

The process that health insurers use to determine health coverage is not always clear, making it hard for patients, providers and biopharmaceutical...
Blog Post

CER Tweets of the Week (June 17-21, 2013)

The Patient-Centered Outcomes Research Institute (PCORI) built buzz on Twitter by launching the PCORI Engagement Awards program, which will grant...

Research

The Myth of Average: Why Individual Patient Differences Matter

Within today’s health care environment, so much of t

Transparency in Evidence Evaluation and Formulary Decision-Making

Although the type of evidence required to make healt

Blue Pill or Red Pill: The Limits of Comparative Effectiveness Research

By choosing "winners and losers," CER drug trials may leave patients who best respond to the "...
  •  
  • 1 of 13
  • >

Commentary & Testimony